Diana Moore

Public Communications Contact en AMICUS THERAPEUTICS, INC. .

Health Technology

Consumer Services

Commercial Services

Perfil

Diana Moore is currently the Head-Global Communications at Amicus Therapeutics, Inc. and is also a Member at the National Investor Relations Institute.
She previously worked as the Director-Investor Relations & Business Development at Advaxis, Inc. Ms. Moore has a graduate degree from The University of Manchester and an undergraduate degree from Princeton University.

Cargos activos de Diana Moore

Empresas	Cargo	Inicio
AMICUS THERAPEUTICS, INC.	Public Communications Contact	01/10/2015
National Investor Relations Institute National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA.	Corporate Officer/Principal	-

Todos los cargos activos de Diana Moore

Antiguos cargos conocidos de Diana Moore.

Empresas	Cargo	Fin
AYALA PHARMACEUTICALS, INC.	Contacto de Relaciones con Inversores	-

Ver el detalle de la experiencia de Diana Moore.

Formación de Diana Moore.

Princeton University	Undergraduate Degree
The University of Manchester	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Diana Moore.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
AMICUS THERAPEUTICS, INC.	Health Technology

Empresas privadas	2
Advaxis, Inc. Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.	Health Technology
National Investor Relations Institute National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA.	Commercial Services